These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11340324)

  • 1. Neuroendocrinology of aging: the potential of gene therapy as an interventive strategy.
    Goya RG; Bolognani F; Hereñú CB; Rimoldi OJ
    Gerontology; 2001; 47(3):168-73. PubMed ID: 11340324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy in the neuroendocrine system: its implementation in experimental models using viral vectors.
    Bolognani F; Goya RG
    Neuroendocrinology; 2001 Feb; 73(2):75-83. PubMed ID: 11244294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy in the neuroendocrine system.
    Hereñú CB; Morel GR; Bellini MJ; Reggiani PC; Sosa YE; Brown OA; Goya RG
    Front Horm Res; 2006; 35():135-142. PubMed ID: 16809929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential of gene therapy for the treatment of pituitary tumors.
    Goya RG; Sarkar DK; Brown OA; Hereñú CB
    Curr Gene Ther; 2004 Mar; 4(1):79-87. PubMed ID: 15032616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neuroendocrine system as a model to evaluate experimental gene therapy.
    Hereñú CB; Brown OA; Sosa YE; Morel GR; Reggiani PC; Bellini MJ; Goya RG
    Curr Gene Ther; 2006 Feb; 6(1):125-9. PubMed ID: 16475950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrinology and aging.
    Epelbaum J
    J Neuroendocrinol; 2008 Jun; 20(6):808-11. PubMed ID: 18601703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy for central diabetes insipidus: effective antidiuresis by muscle-targeted gene transfer.
    Yoshida M; Iwasaki Y; Asai M; Nigawara T; Oiso Y
    Endocrinology; 2004 Jan; 145(1):261-8. PubMed ID: 14525907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue-targeted in vivo gene transfer coupled with histone deacetylase inhibitor depsipeptide (FK228) enhances adenoviral infection in rat renal cancer allograft model systems.
    Kobayashi M; Okada T; Murakami T; Ozawa K; Kobayashi E; Morita T
    Urology; 2007 Dec; 70(6):1230-6. PubMed ID: 18158067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overcoming the immune response to permit ex vivo gene therapy for spine fusion with human type 5 adenoviral delivery of the LIM mineralization protein-1 cDNA.
    Kim HS; Viggeswarapu M; Boden SD; Liu Y; Hair GA; Louis-Ugbo J; Murakami H; Minamide A; Suh DY; Titus L
    Spine (Phila Pa 1976); 2003 Feb; 28(3):219-26. PubMed ID: 12567021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing viral gene therapy in neuroendocrine models.
    Geddes BJ; Harding TC; Lightman SL; Uney JB
    Front Neuroendocrinol; 1999 Oct; 20(4):296-316. PubMed ID: 10569280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroendocrinology and ovarian aging.
    Devoto L; Palomino A; Céspedes P; Kohen P
    Gynecol Endocrinol; 2012 Mar; 28 Suppl 1():14-7. PubMed ID: 22273454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on in vivo gene transfer in pituitary tumors using herpes-derived and adenoviral vectors.
    Carri NG; Sosa YE; Brown OA; Albariño C; Romanowski V; Goya RG
    Brain Res Bull; 2005 Feb; 65(1):17-22. PubMed ID: 15680541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymus and aging: potential of gene therapy for restoration of endocrine thymic function in thymus-deficient animal models.
    Goya RG; Cónsole G; Hereñú C; Brown O; Rimoldi OJ
    Gerontology; 2002; 48(5):325-8. PubMed ID: 12169800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-mediated herpes simplex virus type-1 thymidine kinase gene therapy suppresses oestrogen-induced pituitary prolactinomas.
    Windeatt S; Southgate TD; Dewey RA; Bolognani F; Perone MJ; Larregina AT; Maleniak TC; Morris ID; Goya RG; Klatzmann D; Löwenstein PR; Castro MG
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1296-305. PubMed ID: 10720079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus-based vector improves the tumor cell killing effect of pituitary tumor in HVJ-liposome-mediated transcriptional targeting suicide gene therapy.
    Izumo T; Ohtsuru A; Tokunaga Y; Namba H; Kaneda Y; Nagata I; Yamashita S
    Int J Oncol; 2007 Aug; 31(2):379-87. PubMed ID: 17611695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy for pituitary tumors: from preclinical models to clinical implementation.
    Castro M; Goverdhana S; Hu J; Jovel N; Yuan X; Lowenstein P
    Front Neuroendocrinol; 2003 Jan; 24(1):62-77. PubMed ID: 12609500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine research models.
    Akalan N
    Acta Neurochir Suppl; 2002; 83():85-91. PubMed ID: 12442626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of an E1E4-deleted adenovirus expressing the herpes simplex thymidine kinase suicide gene in cancer gene therapy.
    Lanuti M; Gao GP; Force SD; Chang MY; El Kouri C; Amin KM; Hughes JV; Wilson JM; Kaiser LR; Albelda SM
    Hum Gene Ther; 1999 Feb; 10(3):463-75. PubMed ID: 10048398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of the neuroendocrine system in aging processes.
    Meites J
    Adv Biochem Psychopharmacol; 1987; 43():283-92. PubMed ID: 2884818
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuronal plasticity- a new field in neuroendocrinology.
    Vlad AG
    Endocrinologie; 1987; 25(2):115-9. PubMed ID: 3629149
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.